SELLAS Life Sciences Group, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
SELLAS Life Sciences Group, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • SELLAS Life Sciences Group, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 252 %, a 16.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 252 -50.6 -16.7% Sep 30, 2024
Q2 2024 6.68K +6.52K +3906% Jun 30, 2024
Q1 2024 2K +1.89K +1599% Mar 31, 2024
Q4 2023 898 +750 +506% Dec 31, 2023
Q3 2023 303 +214 +240% Sep 30, 2023
Q2 2023 167 +98.5 +144% Jun 30, 2023
Q1 2023 118 +64.7 +122% Mar 31, 2023
Q4 2022 148 +112 +311% Dec 31, 2022
Q3 2022 89.1 +45 +102% Sep 30, 2022
Q2 2022 68.3 +16.6 +32.1% Jun 30, 2022
Q1 2022 53.2 -21.6 -28.9% Mar 31, 2022
Q4 2021 36 -65.2 -64.4% Dec 31, 2021
Q3 2021 44.1 -113 -72% Sep 30, 2021
Q2 2021 51.7 -92 -64% Jun 30, 2021
Q1 2021 74.8 -30 -28.6% Mar 31, 2021
Q4 2020 101 -28.2 -21.8% Dec 31, 2020
Q3 2020 158 +21.3 +15.6% Sep 30, 2020
Q2 2020 144 +11.1 +8.36% Jun 30, 2020
Q1 2020 105 -218 -67.6% Mar 31, 2020
Q4 2019 129 -378 -74.5% Dec 31, 2019
Q3 2019 136 -586 -81.1% Sep 30, 2019
Q2 2019 133 -919 -87.4% Jun 30, 2019
Q1 2019 323 -90.1 -21.8% Mar 31, 2019
Q4 2018 507 +268 +112% Dec 31, 2018
Q3 2018 722 +488 +208% Sep 30, 2018
Q2 2018 1.05K +829 +373% Jun 30, 2018
Q1 2018 413 +177 +75% Mar 31, 2018
Q4 2017 240 -85.1 -26.2% Dec 31, 2017
Q3 2017 234 -273 -53.8% Sep 30, 2017
Q2 2017 222 -206 -48.1% Jun 30, 2017
Q1 2017 236 -39 -14.2% Mar 31, 2017
Q4 2016 325 +153 +88.9% Dec 31, 2016
Q3 2016 507 +397 +360% Sep 30, 2016
Q2 2016 428 +318 +289% Jun 30, 2016
Q1 2016 275 +151 +121% Mar 31, 2016
Q4 2015 172 +38.9 +29.2% Dec 31, 2015
Q3 2015 110 -94.8 -46.3% Sep 30, 2015
Q2 2015 110 -95 -46.3% Jun 30, 2015
Q1 2015 125 -102 -44.9% Mar 31, 2015
Q4 2014 133 -150 -53% Dec 31, 2014
Q3 2014 205 +37.6 +22.5% Sep 30, 2014
Q2 2014 205 +39.6 +23.9% Jun 30, 2014
Q1 2014 226 +100 +79.6% Mar 31, 2014
Q4 2013 283 +71.1 +33.6% Dec 31, 2013
Q3 2013 167 -139 -45.4% Sep 30, 2013
Q2 2013 166 -284 -63.2% Jun 30, 2013
Q1 2013 126 -844 -87% Mar 31, 2013
Q4 2012 212 Dec 31, 2012
Q3 2012 306 Sep 30, 2012
Q2 2012 450 Jun 30, 2012
Q1 2012 970 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.